New York State Common Retirement Fund Halozyme Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 63,127 shares of HALO stock, worth $4.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
63,127
Previous 246,966 74.44%
Holding current value
$4.42 Million
Previous $12.8 Million 63.97%
% of portfolio
0.01%
Previous 0.02%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025
SELL
$52.92 - $78.28 $9.73 Million - $14.4 Million
-183,839 Reduced 74.44%
63,127 $4.63 Million
Q2 2025

Oct 08, 2025
SELL
$47.91 - $70.14 $2.54 Million - $3.72 Million
-53,035 Reduced 17.68%
246,966 $12.8 Million
Q2 2025

Aug 13, 2025
SELL
$47.91 - $70.14 $2.54 Million - $3.72 Million
-53,035 Reduced 17.68%
246,966 $12.8 Million
Q1 2025

Oct 08, 2025
SELL
$47.74 - $65.16 $3.25 Million - $4.43 Million
-68,009 Reduced 18.48%
300,001 $19.1 Million
Q1 2025

May 01, 2025
SELL
$47.74 - $65.16 $3.25 Million - $4.43 Million
-68,009 Reduced 18.48%
300,001 $19.1 Million
Q4 2024

Oct 08, 2025
SELL
$42.57 - $61.09 $17.1 Million - $24.5 Million
-401,494 Reduced 52.18%
368,010 $17.6 Million
Q4 2024

Jan 31, 2025
SELL
$42.57 - $61.09 $17.1 Million - $24.5 Million
-401,494 Reduced 52.18%
368,010 $17.6 Million
Q3 2024

Oct 08, 2025
BUY
$51.3 - $64.42 $26.8 Million - $33.7 Million
522,538 Added 211.58%
769,504 $44 Million
Q3 2024

Oct 28, 2024
SELL
$51.3 - $64.42 $9.62 Million - $12.1 Million
-187,515 Reduced 19.59%
769,504 $44 Million
Q2 2024

Oct 08, 2025
BUY
$37.81 - $52.4 $26.8 Million - $37.2 Million
710,053 Added 287.51%
957,019 $50.1 Million
Q2 2024

Jul 31, 2024
BUY
$37.81 - $52.4 $1.48 Million - $2.06 Million
39,260 Added 4.28%
957,019 $50.1 Million
Q1 2024

Oct 08, 2025
BUY
$33.68 - $41.95 $22.6 Million - $28.1 Million
670,793 Added 271.61%
917,759 $37.3 Million
Q1 2024

May 07, 2024
SELL
$33.68 - $41.95 $1.06 Million - $1.32 Million
-31,565 Reduced 3.32%
917,759 $37.3 Million
Q4 2023

Oct 08, 2025
BUY
$33.32 - $42.1 $23.4 Million - $29.6 Million
702,358 Added 284.39%
949,324 $35.1 Million
Q4 2023

Feb 01, 2024
SELL
$33.32 - $42.1 $688,891 - $870,417
-20,675 Reduced 2.13%
949,324 $35.1 Million
Q3 2023

Oct 08, 2025
BUY
$36.46 - $44.03 $26.4 Million - $31.8 Million
723,033 Added 292.77%
969,999 $37.1 Million
Q3 2023

Nov 07, 2023
BUY
$36.46 - $44.03 $751,513 - $907,546
20,612 Added 2.17%
969,999 $37.1 Million
Q2 2023

Oct 08, 2025
BUY
$30.28 - $38.74 $21.3 Million - $27.2 Million
702,421 Added 284.42%
949,387 $34.2 Million
Q2 2023

Aug 07, 2023
BUY
$30.28 - $38.74 $3.67 Million - $4.69 Million
121,137 Added 14.63%
949,387 $34.2 Million
Q1 2023

Oct 08, 2025
BUY
$32.86 - $55.7 $925,304 - $1.57 Million
28,159 Added 3.52%
828,250 $31.6 Million
Q1 2023

May 02, 2023
BUY
$32.86 - $55.7 $925,304 - $1.57 Million
28,159 Added 3.52%
828,250 $31.6 Million
Q4 2022

Oct 08, 2025
BUY
$40.06 - $59.44 $22.2 Million - $32.9 Million
553,125 Added 223.97%
800,091 $45.5 Million
Q4 2022

Jan 30, 2023
SELL
$40.06 - $59.44 $6.31 Million - $9.36 Million
-157,420 Reduced 16.44%
800,091 $45.5 Million
Q3 2022

Nov 08, 2022
SELL
$38.53 - $51.78 $565,851 - $760,441
-14,686 Reduced 1.51%
957,511 $37.9 Million
Q2 2022

Aug 04, 2022
SELL
$37.35 - $48.3 $3.84 Million - $4.96 Million
-102,780 Reduced 9.56%
972,197 $42.8 Million
Q1 2022

May 05, 2022
SELL
$31.97 - $41.06 $5.9 Million - $7.57 Million
-184,473 Reduced 14.65%
1,074,977 $42.9 Million
Q4 2021

Feb 02, 2022
SELL
$31.82 - $40.75 $15.6 Million - $20 Million
-489,859 Reduced 28.0%
1,259,450 $50.6 Million
Q3 2021

Nov 02, 2021
BUY
$38.47 - $46.42 $5.15 Million - $6.22 Million
133,986 Added 8.29%
1,749,309 $71.2 Million
Q2 2021

Aug 02, 2021
SELL
$38.84 - $51.31 $2.44 Million - $3.22 Million
-62,815 Reduced 3.74%
1,615,323 $73.4 Million
Q1 2021

May 11, 2021
BUY
$39.51 - $51.45 $3.19 Million - $4.15 Million
80,756 Added 5.06%
1,678,138 $70 Million
Q4 2020

Feb 08, 2021
SELL
$25.81 - $43.62 $1.66 Million - $2.8 Million
-64,274 Reduced 3.87%
1,597,382 $68.2 Million
Q2 2020

Aug 07, 2020
BUY
$16.25 - $26.81 $2 Million - $3.3 Million
123,157 Added 8.01%
1,661,656 $44.5 Million
Q1 2020

May 06, 2020
BUY
$13.9 - $21.83 $9.18 Million - $14.4 Million
660,480 Added 75.22%
1,538,499 $27.7 Million
Q4 2019

Feb 05, 2020
SELL
$14.93 - $19.53 $2.26 Million - $2.96 Million
-151,424 Reduced 14.71%
878,019 $15.6 Million
Q3 2019

Nov 07, 2019
BUY
$15.2 - $17.69 $1.86 Million - $2.16 Million
122,090 Added 13.46%
1,029,443 $16 Million
Q2 2019

Aug 09, 2019
SELL
$14.75 - $17.26 $1.05 Million - $1.23 Million
-71,096 Reduced 7.27%
907,353 $15.6 Million
Q1 2019

May 08, 2019
SELL
$13.94 - $17.58 $970,293 - $1.22 Million
-69,605 Reduced 6.64%
978,449 $15.8 Million
Q4 2018

Feb 08, 2019
BUY
$13.33 - $18.66 $390,355 - $546,439
29,284 Added 2.87%
1,048,054 $15.3 Million
Q3 2018

Nov 07, 2018
BUY
$16.68 - $18.41 $1.7 Million - $1.88 Million
101,886 Added 11.11%
1,018,770 $18.5 Million
Q2 2018

Aug 10, 2018
BUY
$16.87 - $20.3 $649,292 - $781,306
38,488 Added 4.38%
916,884 $15.5 Million
Q1 2018

May 10, 2018
BUY
$17.06 - $21.2 $554,808 - $689,445
32,521 Added 3.84%
878,396 $17.2 Million
Q4 2017

Feb 13, 2018
BUY
$16.75 - $20.8 $93,649 - $116,292
5,591 Added 0.67%
845,875 $17.1 Million
Q3 2017

Nov 06, 2017
BUY
$11.76 - $17.4 $1.06 Million - $1.57 Million
90,243 Added 12.03%
840,284 $14.6 Million
Q2 2017

Aug 11, 2017
BUY
N/A
750,041
750,041 $9.62 Million

Others Institutions Holding HALO

# of Institutions
664
Shares Held
128M
Call Options Held
599K
Put Options Held
455K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $9.75B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email